Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JR

John E. Robinson — 32 Patents

ABArray Biopharma: 22 patents #24 of 335Top 8%
RURoussel Uclaf: 3 patents #127 of 430Top 30%
TLThe Wellcome Foundation Limited: 2 patents #4 of 60Top 7%
Bristol-Myers Squibb: 2 patents #1,827 of 3,969Top 50%
GLGlaxo Group Limited: 2 patents #493 of 1,368Top 40%
RARoche Palo Alto: 1 patents #205 of 347Top 60%
Boulder, CO: #154 of 5,018 inventorsTop 4%
Colorado: #956 of 40,980 inventorsTop 3%
Overall (All Time): #110,428 of 4,157,543Top 3%
32 Patents All Time
John E. Robinson has been granted 32 US patents while listed as an inventor at Array Biopharma. The first was granted in 1992 and the most recent in July 2025. John E. Robinson ranks #110,428 of 4,157,543 US inventors in our database (top 2.7%). Patent records list John E. Robinson in Boulder, CO, US.

Issued Patents All Time

Showing 1–25 of 32 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12351581 Compounds for FGFR inhibition Jay Bradford Fell, John P. Fischer, Logan E. Vine, Martha E. Rodriguez, Jennifer Fulton +9 more 2025-07-08
11247990 Bicyclic fused pyridine compounds as inhibitors of TAM kinases Shelley Allen, Mark Laurence Boys, Adam Cook, John Gaudino, Ronald Jay Hinklin +4 more 2022-02-15
11028093 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more 2021-06-08
10730880 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more 2020-08-04
10189845 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more 2019-01-29 $44,601,000
10017482 Mitotic kinesin inhibitors and methods of use thereof Jeremy Hans, Eli M. Wallace, Qian Zhao, Joseph P. Lyssikatos, Thomas D. Aicher +2 more 2018-07-10 $44,836,000
9499503 Mitotic kinesin inhibitors and methods of use thereof Jeremy Hans, Eli M. Wallace, Qian Zhao, Joseph P. Lyssikatos, Thomas D. Aicher +2 more 2016-11-22 $32,720,000
9221841 Mitotic kinesin inhibitors and methods of use thereof Jeremy Hans, Eli M. Wallace, Qian Zhao, Shelley Allen, Ellen Laird +4 more 2015-12-29 $9,152,000
9102639 Mitotic kinesin inhibitors and methods of use thereof Jeremy Hans, Eli M. Wallace, Qian Zhao, Joseph P. Lyssikatos, Thomas D. Aicher +2 more 2015-08-11 $12,169,000
8987251 Triazolopyridine compounds as PIM kinase inhibitors Shelley Allen, Laura L. Celeste, T. Gregg Davis, Robert Kirk DeLisle, Julie Marie Hicks +13 more 2015-03-24 $16,577,000
8895550 Triazolopyridine compounds as PIM kinase inhibitors Shelley Allen, Robert Kirk DeLisle, Julie Marie Hicks, Erik James Hicken, Joseph P. Lyssikatos +3 more 2014-11-25 $3,103,000
8889704 Triazolopyridine compounds as PIM kinase inhibitors James F. Blake, Robert Kirk DeLisle, Lisa A. De Meese, James Graham, Yvan Le Huerou +4 more 2014-11-18 $5,824,000
8658635 Benzpyrazol derivatives as inhibitors of PI3 kinases Ian Robert Baldwin, Kenneth David Down, Paul Faulder, Simon Gaines, Julie Nicole Hamblin +6 more 2014-02-25
8623895 Mitotic kinesin inhibitors and methods of use thereof Jeremy Hans, Eli M. Wallace, Qian Zhao, Joseph P. Lyssikatos, Thomas D. Aicher +2 more 2014-01-07 $7,919,000
8580828 Mitotic kinesin inhibitors and methods of use thereof Jeremy Hans, Eli M. Wallace, Qian Zhao, Shelley Allen, Ellen Laird +4 more 2013-11-12 $8,302,000
8575145 Triazolopyridine compounds as PIM kinase inhibitors Shelley Allen, Laura L. Celeste, T. Gregg Davis, Robert Kirk DeLisle, Julie Marie Greschuk +13 more 2013-11-05 $8,282,000
8557809 Triazolopyridine compounds as PIM kinase inhibitors Shelley Allen, Robert Kirk DeLisle, Julie Marie Greschuk, Erik James Hicken, Joseph P. Lyssikatos +3 more 2013-10-15 $8,256,000
8324257 Mitotic kinesin inhibitors and methods of use thereof Kateri A. Ahrendt, Robert Kirk DeLisle, Jeremy Hans, Joseph P. Lyssikatos, Eli M. Wallace +1 more 2012-12-04 $2,983,000
8268871 Mitotic kinesin inhibitors and methods of use thereof Jeremy Hans, Eli M. Wallace, Qian Zhao, Shelley Allen, Ellen Laird +4 more 2012-09-18 $3,672,000
8236825 Mitotic kinesin inhibitors and methods of use thereof Jeremy Hans, Eli M. Wallace, Qian Zhao, Joseph P. Lyssikatos, Thomas D. Aicher +2 more 2012-08-07 $6,092,000
8138181 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors Shelley Allen, Julie Marie Greschuk, Nicholas C. Kallan, Fredrik P. Marmsater, Mark Munson +5 more 2012-03-20 $3,648,000
7956073 Mitotic kinesin inhibitors and methods of use thereof Jeremy Hans, Eli M. Wallace, Qian Zhao, Joseph P. Lyssikatos, Thomas D. Aicher +2 more 2011-06-07 $1,153,000
7795282 Mitotic kinesin inhibitors and methods of use thereof Jeremy Hans, Eli M. Wallace, Qian Zhao, Shelley Allen, Ellen Laird +4 more 2010-09-14 $2,600,000
7566786 Quinoline derivatives as phosphodiesterase inhibitors Ian Robert Baldwin, Michael David Barker, Anthony William Dean, Colin David Eldred, Brian Evans +10 more 2009-07-28
7479489 Heterocyclic antiviral compounds James F. Blake, Jay Bradford Fell, John P. Fischer, Robert Than Hendricks, Stacey Spencer +1 more 2009-01-20